The cells harvested on day 7 pt were also analyzed for viral NS1 protein by Western blot. the 5noncoding region of DENV-2 previously shown to be important genetic determinants Rabbit Polyclonal to LMO3 for computer virus replication and mouse virulence were incorporated into the 5 different replicon constructs. Characterizations of 29 mutants exhibited that these replicons can provide a useful platform for a quick and powerfulin vitrosystem to analyze genetic determinants of DENV replication. These constructs can also be useful for development of vectors expressing foreign genes for numerous researches. Keywords:Dengue computer virus type 2, Subgenomic replicons, DENV/GFP plasmid, 5 NCR mutation == 1. Introduction == Dengue computer virus (DENV) is a positive strand RNA computer virus in theFlaviviridaefamily. This computer virus family member includes yellow fever computer virus (YFV), Japanese encephalitis computer virus SR10067 (JEV), West Nile computer virus (WNV), and tick-borne encephalitis computer virus (TBEV). DENV is usually transmitted to humans by infected mosquitoes and causes diseases, ranging from moderate, self-limiting dengue fever, to severe dengue hemorrhagic fever, and dengue shock syndrome. The global distribution of DENV results in more than 50 million cases of contamination, and an estimated 2.5 billion people are at risk each year (Gubler, 2002). Based on unique antigenic characteristics, DENVs are divided into four serotypes; DENV-1, -2, -3 and -4. Re-infection with a second serotype virus increases the risk of developing the more severe dengue hemorrhagic fever/shock syndrome due to induction of antibody-dependent enhancement of the contamination and/or T-cell mediated immunopathogenesis (Halstead et al., 1984;Rothman and Ennis, 1999). Although recent improvements in DENV vaccine development puts several potential candidates on pre-clinical and clinical trials, there is currently no DENV vaccine yet available, partly due to lack of understanding of viral and cellular factors during SR10067 the viral contamination. The positive-strand RNA genome of DENV is usually organized into 5 noncoding region (5NCR)-capsid protein (C)-pre membrane/membrane (prM/M)-envelope protein (E)-non-structural proteins 15 (NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5)-3NCR. The C protein is essential in encapsidation of the viral genome. prM/M protein serves as a chaperon for E protein during protein processing in cells and is involved in maturation of the virions. The mature viral envelope contains the M and E transmembrane proteins. The E protein is responsible for cell receptor binding, induction of the major neutralizing antibody response, mediation of virus-specific membrane fusion in acid pH endosomes, and computer virus assembly in cells. The NS proteins are involved in host cellular immune response, helicase and protease SR10067 enzyme activity, and viral RNA-dependent RNA replication. As with the other positive strand RNA viruses, the 5NCR and 3NCR of DENV are predicted to form secondary RNA structures and cyclization which interact with cellular and viral proteins for viral protein translation (Ali and Siddiqui, 1995) and RNA genome replication (Guesdon et al., 2001;Kuhn et al., 2002). Sequences of 5NCR together with capsid protein gene and 3NCR are required to structurally interact during computer virus replication (Alvarez et al., 2005;You et al., 2001). The functional significance of dengue 5NCR is usually exhibited by the restricted growth of DENV-4 deletion mutants (Cahour et al., 1995), attenuation effect of the DENV-2 PDK-53 vaccine candidate (Butrapet et al., 2000), and reduced computer virus replication of DENV-2 5NCR mutants (Leardkamolkarn et al., 2010;Sirigulpanit et al., 2007). Accumulating data from DENV studies at the molecular level are the basis for dengue vaccine development and anti-DENV drug design. Reporter genes, such as green fluorescent protein (GFP) and luciferase tagged to viruses have been used to study flavivirus biology. Most previous studies reported constructs with parts of the viral structural gene region removed resulting in replicon plasmids that can be replicated in cells. For example, subgenomic WNV replicon expressing reporter gene was developed to promote antiviral drug testing (Lo et al., 2003a;Rossi et al., 2005;Shi et al., 2002). DENV-2 New Guinea C replicons made up of GFP or luciferase reporter stabilized in BHK-21 cells were established for antiviral screening and siRNA screening (Ng et al., 2007). DENV-2 16681 replicon made up of luciferase reporter was created and used to.
